» Authors » Stanislav Tomarev

Stanislav Tomarev

Explore the profile of Stanislav Tomarev including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 1047
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boudkkazi S, Schwenk J, Nakaya N, Brechet A, Kollewe A, Harada H, et al.
Neuron . 2023 Aug; 111(16):2544-2556.e9. PMID: 37591201
Information processing and storage in the brain rely on AMPA-receptors (AMPARs) and their context-dependent dynamics in synapses and extra-synaptic sites. We found that distribution and dynamics of AMPARs in the...
2.
Mead B, Tomarev S
Neural Regen Res . 2021 Aug; 17(3):516-522. PMID: 34380881
miRNA are short non-coding RNA responsible for the knockdown of proteins through their targeting and silencing of complimentary mRNA sequences. The miRNA landscape of a cell thus affects the levels...
3.
Mead B, Cullather E, Nakaya N, Niu Y, Kole C, Ahmed Z, et al.
Exp Eye Res . 2020 Jun; 197:108071. PMID: 32574667
Bone marrow mesenchymal stem cell (BMSC)-derived small extracellular vesicles (sEV) but not fibroblast sEV provide retinal ganglion cell (RGC) neuroprotection both in vitro and in vivo, with miRNAs playing an...
4.
Mead B, Tomarev S
Prog Retin Eye Res . 2020 Mar; 79:100849. PMID: 32169632
Extracellular vesicles (EV), which include exosomes and microvesicles, are secreted from virtually every cell. EV contain mRNA, miRNA, lipids and proteins and can deliver this expansive cargo into nearby cells...
5.
Kole C, Brommer B, Nakaya N, Sengupta M, Bonet-Ponce L, Zhao T, et al.
Invest Ophthalmol Vis Sci . 2020 Feb; 61(2):31. PMID: 32084268
Purpose: To investigate the possible role of activating transcription factor 3 (ATF3) in retinal ganglion cell (RGC) neuroprotection and optic nerve regeneration after optic nerve crush (ONC). Methods: Overexpression of...
6.
Mead B, Chamling X, Zack D, Ahmed Z, Tomarev S
Invest Ophthalmol Vis Sci . 2020 Feb; 61(2):6. PMID: 32031578
Purpose: To determine whether priming of bone marrow mesenchymal stem cells (MSCs) by signals from injured retina, particularly tumor necrosis factor α (TNFα), increase their exosomes' neuroprotective efficacy on retinal...
7.
Mead B, Ahmed Z, Tomarev S
Invest Ophthalmol Vis Sci . 2018 Nov; 59(13):5473-5480. PMID: 30452601
Purpose: To determine if bone marrow-derived stem cell (BMSC) small extracellular vesicles (sEV) promote retinal ganglion cell (RGC) neuroprotection in the genetic DBA/2J mouse model of glaucoma for 12 months....
8.
Mead B, Tomarev S
Neural Regen Res . 2018 Mar; 13(2):228-229. PMID: 29557366
No abstract available.
9.
Mead B, Amaral J, Tomarev S
Invest Ophthalmol Vis Sci . 2018 Feb; 59(2):702-714. PMID: 29392316
Purpose: To investigate the benefit of bone marrow mesenchymal stem cell (BMSC)-derived small extracellular vesicles (sEV) as an intravitreal (ivit) therapy in two rat models of glaucoma and to determine...
10.
Mead B, Tomarev S
Stem Cells Transl Med . 2017 Feb; 6(4):1273-1285. PMID: 28198592
The loss of retinal ganglion cells (RGC) and their axons is one of the leading causes of blindness and includes traumatic (optic neuropathy) and degenerative (glaucoma) eye diseases. Although no...